Inositol 1,4,5-trisphosphate Generation and Calcium Mobilisation Via Activation of an Atypical P2 Receptor in the Neuronal Cell Line, N1E-115
Overview
Affiliations
1. Alterations in the levels of intracellular calcium ([Ca2+]i) and D-myo-inositol-1,4,5-trisphosphate (InsP3) were measured in the murine neuroblastoma cell line clone, N1E-115, by use of the calcium-sensitive dye, fura-2 and a radioreceptor assay, respectively. 2. Exposure of the cells to ATP (100 microM) elicited rapid and transient increases in [Ca2+]i and InsP3, with both responses reaching a maximum between 10-20 s after agonist addition. 3. Investigation of concentration-response data by use of various analogues of ATP suggests the presence of an extracellular receptor which fails to fit into the current classification of purinoceptors. 4. Cross-desensitization experiments suggest that the same receptor can also be activated by the structurally different pyrimidine base, UTP. 5. Application of the tumour-promoting agent, beta-phorbol-12,13 dibutyrate (PDBu) caused a reduction in the increases in both [Ca2+]i and InsP3, suggesting a role for protein kinase C in feedback inhibition of purinoceptor responses in this cell line. 6. In summary, we present the first evidence for the existence of an atypical purinoceptor on a cell line of CNS origin. This receptor is linked to stimulation of phosphoinositide turnover and subsequent mobilisation of intracellular calcium.
Purinergic signalling and cancer.
Burnstock G, Di Virgilio F Purinergic Signal. 2013; 9(4):491-540.
PMID: 23797685 PMC: 3889385. DOI: 10.1007/s11302-013-9372-5.
Dixon C, Cobbold P, Green A Br J Pharmacol. 1995; 116(3):1979-84.
PMID: 8640335 PMC: 1908934. DOI: 10.1111/j.1476-5381.1995.tb16401.x.
Megson A, Dickenson J, Townsend-Nicholson A, Hill S Br J Pharmacol. 1995; 115(8):1415-24.
PMID: 8564200 PMC: 1908880. DOI: 10.1111/j.1476-5381.1995.tb16632.x.
Iredale P, Hill S Br J Pharmacol. 1993; 110(4):1305-10.
PMID: 8306069 PMC: 2175888. DOI: 10.1111/j.1476-5381.1993.tb13960.x.
Pfeilschifter J, Merriweather C Br J Pharmacol. 1993; 110(2):847-53.
PMID: 8242260 PMC: 2175916. DOI: 10.1111/j.1476-5381.1993.tb13890.x.